nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—MTOR—leg—abdominal aortic aneurysm	0.223	0.257	CbGeAlD
Everolimus—MTOR—hindlimb—abdominal aortic aneurysm	0.2	0.229	CbGeAlD
Everolimus—MTOR—blood plasma—abdominal aortic aneurysm	0.0918	0.106	CbGeAlD
Everolimus—FKBP1A—blood plasma—abdominal aortic aneurysm	0.0825	0.0949	CbGeAlD
Everolimus—MTOR—connective tissue—abdominal aortic aneurysm	0.0489	0.0562	CbGeAlD
Everolimus—FKBP1A—connective tissue—abdominal aortic aneurysm	0.0439	0.0505	CbGeAlD
Everolimus—MTOR—kidney—abdominal aortic aneurysm	0.0416	0.0478	CbGeAlD
Everolimus—FKBP1A—kidney—abdominal aortic aneurysm	0.0374	0.043	CbGeAlD
Everolimus—MTOR—spinal cord—abdominal aortic aneurysm	0.0324	0.0372	CbGeAlD
Everolimus—FKBP1A—spinal cord—abdominal aortic aneurysm	0.0291	0.0335	CbGeAlD
Everolimus—CYP3A4—blood plasma—abdominal aortic aneurysm	0.027	0.031	CbGeAlD
Everolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—LDLR—abdominal aortic aneurysm	0.0161	0.123	CbGpPWpGaD
Everolimus—CYP3A4—kidney—abdominal aortic aneurysm	0.0122	0.0141	CbGeAlD
Everolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—abdominal aortic aneurysm	0.00629	0.0483	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00523	0.0401	CbGpPWpGaD
Everolimus—MTOR—SREBP signalling—LDLR—abdominal aortic aneurysm	0.00499	0.0383	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.00438	0.0336	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—MMP14—abdominal aortic aneurysm	0.00405	0.0311	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SERPINE1—abdominal aortic aneurysm	0.00356	0.0273	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.0035	0.0269	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—abdominal aortic aneurysm	0.00332	0.0255	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—NCF1—abdominal aortic aneurysm	0.00328	0.0252	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—NCF1—abdominal aortic aneurysm	0.0031	0.0238	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00279	0.0214	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—NOS2—abdominal aortic aneurysm	0.00269	0.0207	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.00259	0.0199	CbGpPWpGaD
Everolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—abdominal aortic aneurysm	0.00253	0.0194	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00251	0.0193	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00228	0.0175	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.00225	0.0173	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00213	0.0163	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00209	0.016	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.00205	0.0157	CbGpPWpGaD
Everolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00184	0.0141	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.00184	0.0141	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.0018	0.0138	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.00172	0.0132	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00161	0.0124	CbGpPWpGaD
Everolimus—MTOR—Regulation of Telomerase—NFKB1—abdominal aortic aneurysm	0.00155	0.0119	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—abdominal aortic aneurysm	0.00145	0.0111	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—NFKB1—abdominal aortic aneurysm	0.00144	0.011	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00139	0.0107	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—abdominal aortic aneurysm	0.00135	0.0104	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00133	0.0102	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00131	0.0101	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00121	0.00928	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.0012	0.00921	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LRP1—abdominal aortic aneurysm	0.00115	0.00883	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.00108	0.00826	CbGpPWpGaD
Everolimus—FKBP1A—Disease—AAAS—abdominal aortic aneurysm	0.000999	0.00766	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.000876	0.00672	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LDLR—abdominal aortic aneurysm	0.000872	0.00669	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.000852	0.00654	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000821	0.0063	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000819	0.00629	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NCF1—abdominal aortic aneurysm	0.000816	0.00626	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000806	0.00618	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—abdominal aortic aneurysm	0.000757	0.00581	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000754	0.00578	CbGpPWpGaD
Everolimus—MTOR—Immune System—SELL—abdominal aortic aneurysm	0.000728	0.00559	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000723	0.00555	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000669	0.00513	CbGpPWpGaD
Everolimus—MTOR—Disease—LRP1—abdominal aortic aneurysm	0.000647	0.00497	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	0.000647	0.00496	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000611	0.00469	CbGpPWpGaD
Everolimus—MTOR—Immune System—AAAS—abdominal aortic aneurysm	0.000608	0.00467	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000571	0.00438	CbGpPWpGaD
Everolimus—MTOR—Disease—AAAS—abdominal aortic aneurysm	0.000562	0.00431	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	0.000525	0.00403	CbGpPWpGaD
Everolimus—MTOR—Immune System—NCF1—abdominal aortic aneurysm	0.000497	0.00381	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000492	0.00378	CbGpPWpGaD
Everolimus—MTOR—Disease—LDLR—abdominal aortic aneurysm	0.00049	0.00376	CbGpPWpGaD
Everolimus—MTOR—Disease—NCF1—abdominal aortic aneurysm	0.000459	0.00352	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000459	0.00352	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000453	0.00348	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOE—abdominal aortic aneurysm	0.000452	0.00347	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000424	0.00325	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS2—abdominal aortic aneurysm	0.000421	0.00323	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000409	0.00314	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SERPINE1—abdominal aortic aneurysm	0.000354	0.00272	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000343	0.00264	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000323	0.00248	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000321	0.00246	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000316	0.00243	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—abdominal aortic aneurysm	0.000309	0.00237	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000281	0.00216	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00027	0.00207	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000266	0.00204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000258	0.00198	CbGpPWpGaD
Everolimus—MTOR—Disease—APOE—abdominal aortic aneurysm	0.000254	0.00195	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000248	0.0019	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—abdominal aortic aneurysm	0.000237	0.00182	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00023	0.00176	CbGpPWpGaD
Everolimus—MTOR—Disease—SERPINE1—abdominal aortic aneurysm	0.000199	0.00153	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00019	0.00146	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000188	0.00144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000181	0.00139	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000178	0.00136	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—abdominal aortic aneurysm	0.000174	0.00134	CbGpPWpGaD
Everolimus—MTOR—Immune System—NFKB1—abdominal aortic aneurysm	0.000164	0.00126	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000149	0.00115	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00014	0.00107	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.000125	0.000958	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000109	0.000836	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000107	0.00082	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000106	0.000812	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	5.76e-05	0.000442	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	5.64e-05	0.000433	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	3.86e-05	0.000297	CbGpPWpGaD
